Atlas Trials

Menstrual Blood-Derived Mesenchymal Stem Cell Injection (SC01009) in the Treatment of Idiopathic Pulmonary Fibrosis

Clinical trial NCT07131150 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07131150
Sponsor
Ruijin Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Idiopathic Pulmonary Fibrosis (IPF)
Start date
2025-08-31
Primary completion
2028-07-31
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.